Home/ Stocks/ LEGN

Legend Biotech Corporation American Depositary Shares

LEGN XNAS

$20.75 +1.69 (+8.77%) ▲ 15-min delayed

Open

$20.02

High

$20.86

Low

$19.84

Volume

2.61M

Market Cap

$3.73B

About Legend Biotech Corporation American Depositary Shares

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Employees: 3.1K Website →

Related Market News

No specific coverage for LEGN yet. Check out our latest market news or earnings calendar.

Get LEGN Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Legend Biotech Corporation American Depositary Shares.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.